BDA 1.06% 46.5¢ bod australia limited

Ann: Clinical Trial demonstrates Bod's CBD Wafer superiority

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. lightbulb Created with Sketch. 851
    • Release Date: 26/03/19 09:44
    • Summary: Clinical Trial demonstrates Bod's CBD Wafer superiority
    • Price Sensitive: Yes
    • Download Document    Not available as of the moment.
 
watchlist Created with Sketch. Add BDA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.